glp-1 news november 2025 today Poll: 1 in 8 Adults Say They Are Currently Taking a Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford KFF Health Tracking Poll: Prescription

This makes the ServoPen a sustainable choice for ongoing GLP-1 treatment, particularly in regions where cost effectiveness and long-term adherence are priorities

2015GLP-1R agonists modulate enteric immune responses through the intestinal intraepithelial lymphocyte GLP-1R

The anti-inflammatory effects alone make them worth considering for people with both obesity and depression, especially when inflammation appears to be a significant factor

When that same excess fat is driving sleep apnea, joint pain, prediabetes, or PCOS, it becomes clinical obesity, a disease causing real harm

Physiol Rev (2011) 91:102370

PlexusDx compounded semaglutide injection users should report persistent gastrointestinal concerns to their prescribing provider, who can adjust your protocol or refer you for further evaluation if needed